Status:
UNKNOWN
The Learning Curve of Transurethral Holmium Laser Enucleation of the Prostate, Prospective Assessment
Lead Sponsor:
Mansoura University
Conditions:
Learning Curve
Laser
Eligibility:
MALE
40+ years
Phase:
NA
Brief Summary
Despite the high-quality evidence supporting the safety and efficacy of Holmium laser enucleation of the prostate (HOLEP), wide adoption of the procedure is hindered by learning difficulties. Veil-spa...
Detailed Description
INTRODUCTION Holmium laser enucleation of the prostate (HoLEP) was described in 1998 1 and since then, it has the highest level of evidence supporting its safety, efficacy and durability in treating b...
Eligibility Criteria
Inclusion
- Patients with prostate volume (≥40 cc) who are indicated for transurethral surgery for the BPO.
Exclusion
- Patients with IPSS \<13.
- Patients with Qmax \>15 mL/s.
- Presence of urethral stricture.
- Patients with neurogenic bladder.
- Patients with prostate cancer.
- Patients with previous prostate surgery.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06038890
Start Date
August 1 2023
End Date
December 1 2025
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and nephrology center
Al Mansurah, DK, Egypt, 35516